Publications MD C.P. Peters
- Positions
- Other Academic Staff, Medical Specialist
- Main activities
- Research
- Specialisation
- Gastroenterology and Hepatology
- Focus of research
Little is known about the etiology of inflammatory bowel disease. I am currently investigating the role of innate lymphoid cells, which are part of the innate immune system in Crohn's disease. Results of this study may lead to new drug targets to treat patients with Crohn's disease.
Amsterdam UMC Research Institutes
AMC departments
All publications
2019
- Peters Charlotte P., den Hoed Caroline M., Coenen Sandra, Biermann Katharina E., de Man Robert A. Acuut leverfalen na gebruik van voedingssupplementen Nederlands tijdschrift voor geneeskunde 2019;163 (17) [PubMed]
2018
- Bloemendaal Felicia M., Koelink Pim J., van Schie Karin A., Rispens Theo, Peters Charlotte P., Buskens Christianne J., van der Bilt Jarmila D., Bemelman Willem A., Korf Hannelie, Sabino João G., Ponsioen Cyriel Y., te Velde Anje A., D'Haens Geert R. A. M., Vermeire Severine, van den Brink Gijs R., Wildenberg Manon E. TNF-anti-TNF immune complexes inhibit IL-12/IL-23 secretion by inflammatory macrophages via an fc-dependent mechanism Journal of Crohn s & colitis 2018;12 (9):1122-1130 [PubMed]
2014
- Peters Charlotte P., Eshuis Emma J., Toxopeüs Florien M., Hellemons Merel E., Jansen Jeroen M., D'Haens Geert R. A. M., Fockens Paul, Stokkers Pieter C. F., Tuynman Hans A. R. E., van Bodegraven Adriaan A., Ponsioen Cyriel Y. Adalimumab for Crohn's disease: long-term sustained benefit in a population-based cohort of 438 patients Journal of Crohn s & colitis 2014;8 (8):866-875 [PubMed]
- Wolfkamp Simone C. S., Verseyden Caroline, Vogels Esther W. M., Meisner Sander, Boonstra Kirsten, Peters Charlotte P., Stokkers Pieter C. F., te Velde Anje A. ATG16L1 and NOD2 polymorphisms enhance phagocytosis in monocytes of Crohn's disease patients World journal of gastroenterology 2014;20 (10):2664-2672 [PubMed]
- Peters Charlotte P. Crohn's disease: mucosal immunology and immune modulating therapy 2014. 187p. ISBN 9789462590625. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Spits H., Fockens P.; Co-supervisors: te Velde A. A., Ponsioen C. Y.)
- Brandse Johannan F., Peters Charlotte P., Gecse Krisztina B., Eshuis Emma J., Jansen Jeroen M., Tuynman Hans A., Löwenberg Mark, Ponsioen Cyriel Y., van den Brink Gijs R., Dʼhaens Geert R. Effects of infliximab retreatment after consecutive discontinuation of infliximab and adalimumab in refractory Crohn's disease Inflammatory bowel diseases 2014;20 (2):251-258 [PubMed]
- van der Have Mike, Belderbos Tim D. G., Fidder Herma H., Leenders Max, Dijkstra Gerard, Peters Charlotte P., Eshuis Emma J., Ponsioen Cyriel Y., Siersema Peter D., van Oijen Martijn G. H., Oldenburg Bas Screening prior to biological therapy in Crohn's disease: adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study Digestive and liver disease 2014;46 (10):881-886 [PubMed]
2013
- Bernink Jochem H., Peters Charlotte P., Munneke Marius, te Velde Anje A., Meijer Sybren L., Weijer Kees, Hreggvidsdottir Hulda S., Heinsbroek Sigrid E., Legrand Nicolas, Buskens Christianne J., Bemelman Willem A., Mjösberg Jenny M., Spits Hergen Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues Nature immunology 2013;14 (3):221-229 [PubMed]
- Eshuis Emma J., Peters Charlotte P., van Bodegraven Adriaan A., Bartelsman Joep F., Bemelman Willem, Fockens Paul, D'Haens Geert R. A. M., Stokkers Pieter C. F., Ponsioen Cyriel Y. Ten Years of Infliximab for Crohn's Disease: Outcome in 469 Patients from 2 Tertiary Referral Centers Inflammatory bowel diseases 2013;19 (8):1622-1630 [PubMed]
2012
- Kammeyer Arthur, Peters Charlotte P., Meijer Sybren L., te Velde Anje A. Anti-inflammatory effects of urocanic Acid derivatives in models ex vivo and in vivo of inflammatory bowel disease ISRN Inflammation 2012;2012:898153-- [PubMed]
- Hoorweg Kerim, Peters Charlotte P., Cornelissen Ferry, Aparicio-Domingo Patricia, Papazian Natalie, Kazemier Geert, Mjösberg Jenny M., Spits Hergen, Cupedo Tom Functional differences between human NKp44(-) and NKp44(+) RORC+ innate lymphoid cells Frontiers in immunology 2012;3:72 [PubMed]
- Mjösberg Jenny, Bernink Jochem, Golebski Korneliusz, Karrich Julien J., Peters Charlotte P., Blom Bianca, te Velde Anje A., Fokkens Wytske J., van Drunen Cornelis M., Spits Hergen The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells Immunity 2012;37 (4):649-659 [PubMed]
- Mjösberg Jenny, Bernink Jochem, Peters Charlotte, Spits Hergen Transcriptional control of innate lymphoid cells European journal of immunology 2012;42 (8):1916-1923 [PubMed]
2011
- Vlaar Alexander P. J., Kulik Wim, Nieuwland Rienk, Peters Charlotte P., Tool Anton T. J., van Bruggen Robin, Juffermans Nicole P., de Korte Dirk Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent Transfusion 2011;51 (11):2358-2366 [PubMed]
- Mjösberg Jenny M., Trifari Sara, Crellin Natasha K., Peters Charlotte P., van Drunen Cornelis M., Piet Berber, Fokkens Wytske J., Cupedo Tom, Spits Hergen Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161 Nature immunology 2011;12 (11):1055-1062 [PubMed]